Goldman Sachs
CELL

Goldman Sachs’s PhenomeX Inc. Common Stock CELL Stock Holding History

Goldman Sachs’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-232,070
Closed -$114K – 5992
2023
Q2 		$114K Buy
232,070
+30,288
+15% +$24.8K ﹤0.01% 5338
2023
Q1 		$234K Sell
201,782
-11,831
-6% -$21.6K ﹤0.01% 5230
2022
Q4 		$572K Buy
213,613
+13,535
+7% +$35.7K ﹤0.01% 4800
2022
Q3 		$572K Sell
200,078
-215,146
-52% -$915K ﹤0.01% 4889
2022
Q2 		$2.06M Buy
415,224
+258,439
+165% +$1.35M ﹤0.01% 4019
2022
Q1 		$1.11M Sell
156,785
-80,248
-34% -$664K ﹤0.01% 4731
2021
Q4 		$4.31M Sell
237,033
-224,945
-49% -$4.85M ﹤0.01% 3558
2021
Q3 		$9.04M Buy
461,978
+148,924
+48% +$5.66M ﹤0.01% 2827
2021
Q2 		$14M Sell
313,054
-112,985
-27% -$5.24M ﹤0.01% 2373
2021
Q1 		$21.4M Buy
426,039
+248,822
+140% +$17M 0.01% 1878
2020
Q4 		$15.8M Buy
177,217
+30,188
+21% +$2.54M ﹤0.01% 2047
2020
Q3 		$11.2M Buy
+147,029
New +$9.34M ﹤0.01% 2218

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs's CELL Position: Q3 2023 in Review

Goldman Sachs sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 232,070 shares — an estimated $114K sold.

Goldman Sachs first reported a position in CELL in Q3 2020 and held it in 12 quarters. The position peaked at $21.4M in Q1 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Goldman Sachs reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Goldman Sachs sold 232,070 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $114K.
  • Goldman Sachs first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 12 quarters.
  • Goldman Sachs's PhenomeX Inc. Common Stock position peaked at $21.4M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Goldman Sachs's 13F filing for Q3 2023, filed 14 Nov 2023.